This page is part of the US Drug Formulary (v2.0.1: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/us/davinci-drug-formulary/ValueSet/DrugTierVS | Version: 2.0.1 | |||
Standards status: Trial-use | Computable Name: DrugTierVS |
The drug tier of a particular medication in a health plan. The base set are examples. Each plan may have its own controlled vocabulary.
References
http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE
Expansion based on codesystem Codes for medication drug tiers in health plans v2.0.1 (CodeSystem)
This value set contains 9 concepts
Code | System | Display | Definition |
generic | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Generic | Commonly prescribed generic drugs that cost more than drugs in the ‘preferred generic’ tier. |
preferred-generic | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Preferred Generic | Commonly prescribed generic drugs. |
non-preferred-generic | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Non-preferred Generic | Generic drugs that cost more than drugs in ‘generic’ tier. |
specialty | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Specialty | Drugs used to treat complex conditions like cancer and multiple sclerosis. They can be generic or brand name, and are typically the most expensive drugs on the formulary. |
brand | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Brand | Brand name drugs that cost more than ‘preferred brand’ drugs. |
preferred-brand | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Preferred Brand | Brand name drugs |
non-preferred-brand | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Non-preferred Brand | Brand name drugs that cost more than ‘brand’ drugs. |
zero-cost-share-preventative | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Zero cost-share preventative | Preventive medications and products available at no cost. |
medical-service | http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE | Medical Service | Drugs that must be administered by a clinician or in a facility and may be covered under a medical benefit. |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |